Table 1 Baseline characteristics of the patients
All patients (n = 369) | NSTEMI (n = 84) | UA (n = 130) | Cardiac but not ACS (n = 28) | Non-Cardiac (n = 127) | P value | |
---|---|---|---|---|---|---|
Age, year | 62 (55–69) | 59 (50.3–65) | 65 (58–71) | 62.5 (53–67) | 62 (55–68) | <0.001 |
Female sex, no. (%) | 144 (39.0%) | 19 (22.6%) | 50 (38.5%) | 10 (35.7%) | 65 (51.2%) | 0.001 |
Body mass index, kg/m2 | 25.8 (23.6–28.3) | 24.9 (24.0–28.3) | 26.0 (23.8–28.4) | 26.3 (24.0–27.9) | 25.0 (22.1–27.9) | 0.354 |
Chest Pain Onset (n = 369) | ||||||
Time since CPO, h | 4.0 (2.0–6.5) | 5.0 (2.0–8.0) | 4.0 (2.0–6.0) | 3.3 (2.0–6.0) | 4.0 (2.0–7.0) | 0.583 |
Early presenters (<3 h after CPO) | 122 (33.1%) | 27 (32.1%) | 45 (34.6%) | 8 (28.6%) | 42 (33.1%) | 0.934 |
Risk factors, no. (%) | ||||||
Hypertension (n = 369) | 254 (68.8%) | 63 (75%) | 96 (73.8%) | 18 (64.3%) | 77 (60.6%) | 0.064 |
Hypercholesterolemia (n = 348) | 220 (63.2%) | 66 (79.5%) | 96 (75.6%) | 20 (74.1%) | 38 (34.2%) | <0.001 |
Diabetes (n = 348) | 112 (32.2%) | 27 (32.5%) | 55 (43.3%) | 7 (25.9%) | 23 (20.7%) | 0.002 |
Smoking History (n = 350) | 150 (42.9%) | 53 (63.9%) | 63 (49.6%) | 14 (51.9%) | 20 (17.7%) | <0.001 |
History, no. (%) | ||||||
Coronary artery disease (n = 358) | 146 (40.8%) | 30 (36.1%) | 86 (67.2%) | 9 (33.3%) | 21 (17.5%) | <0.001 |
Previous MI (n = 350) | 37 (10.6%) | 14 (16.9%) | 19 (15.0%) | 1 (3.7%) | 3 (2.7%) | 0.001 |
Previous PCI (n = 349) | 70 (20.1%) | 13 (15.9%) | 46 (36.2%) | 2 (7.4%) | 9 (8.0%) | <0.001 |
Previous CABG (n = 350) | 3 (0.9%) | 1 (1.2%) | 2 (1.6%) | 0 (0.0%) | 0 (0.0%) | 0.591 |
Cerebrovascular Disease (n = 350) | 31 (8.9%) | 8 (9.6%) | 14 (11.0%) | 2 (7.4%) | 7 (6.2%) | 0.603 |
Previous insulin use (n = 350) | 36 (10.3%) | 5 (6.0%) | 16 (12.6%) | 1 (3.7%) | 14 (12.4%) | 0.275 |
Laboratory findings | ||||||
Creatinine, umol/L (n = 355) | 71.4 (60.9–84.3) | 69.3 (59.4–84.5) | 73.4 (62–84.8) | 68.8 (57.2–89) | 73.2 (60.3–83.3) | 0.762 |
Chronic medication, no. (%) | ||||||
Aspirin and P2Y12 receptor antagonist (n = 343) | 126 (36.7%) | 30 (37.5%) | 68 (53.1%) | 6 (22.2%) | 22 (20.4%) | <0.001 |
Statins (n = 343) | 147 (42.9%) | 32 (40.0%) | 78 (60.9%) | 9 (33.3%) | 28 (25.9%) | <0.001 |